Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Immunology, Immunotherapy : CII|February 15, 2002
A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinomaShin-ichi Takemura, Toshio Kudo, Ryutaro Asano, et al.
Immunology Letters|February 20, 2002
Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodiesHideaki Kodama, Masanori Suzuki, Yu Katayose, et al.
Journal of Gastroenterology and Hepatology|July 19, 2008
Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single centerAkira Hiramatsu, Shoichi Takahashi, Hiroshi Aikata, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2003
A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cellsHiroki Hayashi, Ryutaro Asano, Kouhei Tsumoto, et al.
Journal of Gastroenterology and Hepatology|April 10, 2008
Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapySoocheol Jeong, Yoshiiku Kawakami, Mikiya Kitamoto, et al.
World Journal of Gastroenterology|September 19, 2007
Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinomaSoocheol Jeong, Hiroshi Aikata, Yoshio Katamura, et al.
World Journal of Gastroenterology|September 20, 2007
Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinomaSoo Cheol Jeong, Hiroshi Aikata, Yoshio Katamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2011
Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombusHideaki Kodama, Hiroshi Aikata, Eisuke Murakami, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2020
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive ProceduresYuno Nishida, Tomokazu Kawaoka, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2020
Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosisKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
Pageof 2